Uciane Scarlett

Nov 2, 2024 | insights.citeline.com | Dennis Chang |Keith T Flaherty |Uciane Scarlett

A Tale Of Two PipelinesThe Promise And Pitfalls Of IO Exuberance And How To Rethink The Approach To Cancer Innovation21 Jan 2020 • By Dennis Chang, Keith Flaherty, and Uciane ScarlettImmuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results.